RecruitingNCT07118280

Oral Health, Saliva Viscosity and Composition in Oculo-Pharyngeal Muscular Dystrophy (OPMD)

Saliva Composition in Oculo-Pharyngeal Muscular Dystrophy (OPMD)


Sponsor

Sheba Medical Center

Enrollment

100 participants

Start Date

Mar 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to explore whether oral health and saliva viscosity and composition in Oculopharyngeal Muscular Dystrophy (OPMD) is different from control subjects. The main questions it aims to answer are: Do swallowing disturbances in OPMD adversely affect oral health? Is saliva thickness (viscosity) is increased in OPMD? Does saliva in OPMD contains biochemical markers of the disease?


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Patients with OPMD and their spouses or household members

Exclusion Criteria1

  • Pregnancy or presence of any disease that may affect a composition of saliva

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Sheba Medical Center

Ramat Gan, Israel

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07118280


Related Trials